Evaluation of susceptibility and synergism activities with Laurus nobilis (Lauraceae) essential oil and antimicrobial drugs against bacterial strains

Detalhes bibliográficos
Autor(a) principal: Lima, Willian Artner de
Data de Publicação: 2022
Outros Autores: Fernandes, Lidiane Aparecida
Tipo de documento: Artigo
Idioma: por
Título da fonte: Revista Fitos
Texto Completo: https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1392
Resumo: Studies for the development of new drugs do not keep pace with increasing bacterial resistance. The use of essential oil can help in this process since it has a great diversity of aromatic compounds with antimicrobial characteristics, so they can be used synergistically to enhance the effect of the drug. This paper is justified by the importance of testing in vitro of essential oils already known as the original substance front the strains bacterial, Staphylococcus aureus ATCC 25923, Streptococcus pyogenes ATCC 19615, Pseudomonas aeruginosas ATCC 27853 and Escherichia coli ATCC 25922, to praise the research of medicinal plants. The research objectives: evaluate the activity antimicrobial of the Essential Oil of Laurus nobilis L. on strains bacterial, to extract the essential oil; to compare the effectiveness of using essential oil to conventional antibiotics; test the inhibitory effect of commercial oil of Laurel, Laurus nobilis L., and the extracted one. Susceptibility testing with oils essential in isolated ways did not present an expected result against the bacterial strains used. The commercial oil showed a small advantage against the extracted oil. However, the synergism test made with the extracted oil with antibiotics has shown considerable effectiveness for bacteria Escherichia coli and Staphylococcus aureus.
id FIOCRUZ-1_6afc02071394ddfa40430111fbbd8c83
oai_identifier_str oai:ojs.revistafitos.far.fiocruz.br:article/1392
network_acronym_str FIOCRUZ-1
network_name_str Revista Fitos
repository_id_str
spelling Evaluation of susceptibility and synergism activities with Laurus nobilis (Lauraceae) essential oil and antimicrobial drugs against bacterial strainsAvaliação das atividades de suscetibilidade e sinergismo com o óleo essencial de Laurus nobilis (Lauraceae) e fármacos antimicrobianos contra cepas bacterianasÓleo essencialAntimicrobianoSinergismoPlantas medicinaisLaurus nobilis LEssential oilAntimicrobialSynergismMedicinal plantsLaurus nobilis LStudies for the development of new drugs do not keep pace with increasing bacterial resistance. The use of essential oil can help in this process since it has a great diversity of aromatic compounds with antimicrobial characteristics, so they can be used synergistically to enhance the effect of the drug. This paper is justified by the importance of testing in vitro of essential oils already known as the original substance front the strains bacterial, Staphylococcus aureus ATCC 25923, Streptococcus pyogenes ATCC 19615, Pseudomonas aeruginosas ATCC 27853 and Escherichia coli ATCC 25922, to praise the research of medicinal plants. The research objectives: evaluate the activity antimicrobial of the Essential Oil of Laurus nobilis L. on strains bacterial, to extract the essential oil; to compare the effectiveness of using essential oil to conventional antibiotics; test the inhibitory effect of commercial oil of Laurel, Laurus nobilis L., and the extracted one. Susceptibility testing with oils essential in isolated ways did not present an expected result against the bacterial strains used. The commercial oil showed a small advantage against the extracted oil. However, the synergism test made with the extracted oil with antibiotics has shown considerable effectiveness for bacteria Escherichia coli and Staphylococcus aureus.Os estudos para o desenvolvimento de novos fármacos não acompanham o mesmo ritmo que cresce a resistência bacteriana. O uso do óleo essencial poderá auxiliar nesse processo, possui uma grande diversidade de compostos aromáticos com características antimicrobianas, podendo ser utilizados de forma sinérgica, para potencializar o efeito do fármaco. O presente trabalho justifica-se pela importância de testar in vitro os óleos essenciais, frente às cepas bacterianas Staphylococcus aureus ATCC 25923, Streptococcus pyogenes ATCC 19615, Pseudomonas aeruginosas ATCC 27853 e a Escherichia coli ATCC 25922, com o intuito de enaltecer a pesquisa de plantas medicinais. Os objetivos da pesquisa consistem em: avaliar a atividade antimicrobiana do óleo essencial de Laurus nobilis L. sobre cepas bacterianas; extrair o óleo essencial; comparar a eficácia do óleo essencial em relação a antibióticos convencionais; testar o efeito inibitório do óleo comercial de Louro, Laurus nobilis L., e o extraído. O teste de suscetibilidade com os óleos essenciais de forma isolada, não apresentou resultado esperado, mas o óleo comercial apresentou uma pequena vantagem contra o óleo extraído, porém o teste de sinergismo realizado com o óleo extraído e os antibióticos revelaram uma efetividade considerável para as bactérias Escherichia coli e Staphylococcus aureus.Centro de Inovação em Biodiversidade e Saúde - Farmanguinhos/Fiocruz2022-12-20info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdftext/htmltext/xmlhttps://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/139210.32712/2446-4775.2022.1392Revista Fitos; Vol. 16 No. 4 (2022); 431-442Revista Fitos; Vol. 16 Núm. 4 (2022); 431-442Revista Fitos; v. 16 n. 4 (2022); 431-4422446-47751808-9569reponame:Revista Fitosinstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZporhttps://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1392/1103https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1392/1104https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1392/1339Copyright (c) 2022 Revista Fitoshttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessLima, Willian Artner deFernandes, Lidiane Aparecida2022-12-20T17:55:43Zoai:ojs.revistafitos.far.fiocruz.br:article/1392Revistahttps://revistafitos.far.fiocruz.br/index.php/revista-fitos/PUBhttp://revistafitos.far.fiocruz.br/index.php/revista-fitos/oairevistafitos@far.fiocruz.br || eugenio.telles@far.fiocruz.br2446-47752446-4775opendoar:2022-12-20T17:55:43Revista Fitos - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.none.fl_str_mv Evaluation of susceptibility and synergism activities with Laurus nobilis (Lauraceae) essential oil and antimicrobial drugs against bacterial strains
Avaliação das atividades de suscetibilidade e sinergismo com o óleo essencial de Laurus nobilis (Lauraceae) e fármacos antimicrobianos contra cepas bacterianas
title Evaluation of susceptibility and synergism activities with Laurus nobilis (Lauraceae) essential oil and antimicrobial drugs against bacterial strains
spellingShingle Evaluation of susceptibility and synergism activities with Laurus nobilis (Lauraceae) essential oil and antimicrobial drugs against bacterial strains
Lima, Willian Artner de
Óleo essencial
Antimicrobiano
Sinergismo
Plantas medicinais
Laurus nobilis L
Essential oil
Antimicrobial
Synergism
Medicinal plants
Laurus nobilis L
title_short Evaluation of susceptibility and synergism activities with Laurus nobilis (Lauraceae) essential oil and antimicrobial drugs against bacterial strains
title_full Evaluation of susceptibility and synergism activities with Laurus nobilis (Lauraceae) essential oil and antimicrobial drugs against bacterial strains
title_fullStr Evaluation of susceptibility and synergism activities with Laurus nobilis (Lauraceae) essential oil and antimicrobial drugs against bacterial strains
title_full_unstemmed Evaluation of susceptibility and synergism activities with Laurus nobilis (Lauraceae) essential oil and antimicrobial drugs against bacterial strains
title_sort Evaluation of susceptibility and synergism activities with Laurus nobilis (Lauraceae) essential oil and antimicrobial drugs against bacterial strains
author Lima, Willian Artner de
author_facet Lima, Willian Artner de
Fernandes, Lidiane Aparecida
author_role author
author2 Fernandes, Lidiane Aparecida
author2_role author
dc.contributor.author.fl_str_mv Lima, Willian Artner de
Fernandes, Lidiane Aparecida
dc.subject.por.fl_str_mv Óleo essencial
Antimicrobiano
Sinergismo
Plantas medicinais
Laurus nobilis L
Essential oil
Antimicrobial
Synergism
Medicinal plants
Laurus nobilis L
topic Óleo essencial
Antimicrobiano
Sinergismo
Plantas medicinais
Laurus nobilis L
Essential oil
Antimicrobial
Synergism
Medicinal plants
Laurus nobilis L
description Studies for the development of new drugs do not keep pace with increasing bacterial resistance. The use of essential oil can help in this process since it has a great diversity of aromatic compounds with antimicrobial characteristics, so they can be used synergistically to enhance the effect of the drug. This paper is justified by the importance of testing in vitro of essential oils already known as the original substance front the strains bacterial, Staphylococcus aureus ATCC 25923, Streptococcus pyogenes ATCC 19615, Pseudomonas aeruginosas ATCC 27853 and Escherichia coli ATCC 25922, to praise the research of medicinal plants. The research objectives: evaluate the activity antimicrobial of the Essential Oil of Laurus nobilis L. on strains bacterial, to extract the essential oil; to compare the effectiveness of using essential oil to conventional antibiotics; test the inhibitory effect of commercial oil of Laurel, Laurus nobilis L., and the extracted one. Susceptibility testing with oils essential in isolated ways did not present an expected result against the bacterial strains used. The commercial oil showed a small advantage against the extracted oil. However, the synergism test made with the extracted oil with antibiotics has shown considerable effectiveness for bacteria Escherichia coli and Staphylococcus aureus.
publishDate 2022
dc.date.none.fl_str_mv 2022-12-20
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1392
10.32712/2446-4775.2022.1392
url https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1392
identifier_str_mv 10.32712/2446-4775.2022.1392
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1392/1103
https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1392/1104
https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1392/1339
dc.rights.driver.fl_str_mv Copyright (c) 2022 Revista Fitos
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2022 Revista Fitos
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
text/html
text/xml
dc.publisher.none.fl_str_mv Centro de Inovação em Biodiversidade e Saúde - Farmanguinhos/Fiocruz
publisher.none.fl_str_mv Centro de Inovação em Biodiversidade e Saúde - Farmanguinhos/Fiocruz
dc.source.none.fl_str_mv Revista Fitos; Vol. 16 No. 4 (2022); 431-442
Revista Fitos; Vol. 16 Núm. 4 (2022); 431-442
Revista Fitos; v. 16 n. 4 (2022); 431-442
2446-4775
1808-9569
reponame:Revista Fitos
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Revista Fitos
collection Revista Fitos
repository.name.fl_str_mv Revista Fitos - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv revistafitos@far.fiocruz.br || eugenio.telles@far.fiocruz.br
_version_ 1798313476062445568